KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Payables (2016 - 2025)

Historic Payables for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $3.0 billion.

  • Colgate Palmolive's Payables rose 3972.8% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 3972.8%. This contributed to the annual value of $2.5 billion for FY2024, which is 2154.83% up from last year.
  • Latest data reveals that Colgate Palmolive reported Payables of $3.0 billion as of Q3 2025, which was up 3972.8% from $3.4 billion recorded in Q2 2025.
  • Colgate Palmolive's 5-year Payables high stood at $3.4 billion for Q2 2025, and its period low was $1.3 billion during Q3 2021.
  • In the last 5 years, Colgate Palmolive's Payables had a median value of $1.6 billion in 2022 and averaged $1.9 billion.
  • Over the last 5 years, Colgate Palmolive's Payables had its largest YoY gain of 6476.28% in 2025, and its largest YoY loss of 1682.07% in 2025.
  • Quarter analysis of 5 years shows Colgate Palmolive's Payables stood at $1.5 billion in 2021, then rose by 2.9% to $1.6 billion in 2022, then grew by 29.83% to $2.0 billion in 2023, then grew by 21.55% to $2.5 billion in 2024, then increased by 20.85% to $3.0 billion in 2025.
  • Its Payables stands at $3.0 billion for Q3 2025, versus $3.4 billion for Q2 2025 and $1.8 billion for Q1 2025.